Inflammation and cancer: when NF-κB amalgamates the perilous partnership

MA Dobrovolskaia, SV Kozlov - Current cancer drug targets, 2005 - ingentaconnect.com
MA Dobrovolskaia, SV Kozlov
Current cancer drug targets, 2005ingentaconnect.com
Chronic inflammation has long been suggested to constitute a risk factor for a variety of
epithelial cancers such as malignancies of prostate, cervix, esophagus, stomach, liver,
colon, pancreas, and bladder. An inflammatory response is typically accompanied by
generation of free radicals, stimulation of cytokines, chemokines, growth and angiogenic
factors. Free radicals, capable of both directly damaging DNA and affecting the DNA repair
machinery, enhance genetic instability of affected cells, thus contributing to the first stage of …
Chronic inflammation has long been suggested to constitute a risk factor for a variety of epithelial cancers such as malignancies of prostate, cervix, esophagus, stomach, liver, colon, pancreas, and bladder. An inflammatory response is typically accompanied by generation of free radicals, stimulation of cytokines, chemokines, growth and angiogenic factors. Free radicals, capable of both directly damaging DNA and affecting the DNA repair machinery, enhance genetic instability of affected cells, thus contributing to the first stage of neoplastic transformation also known as
ingentaconnect.com